nemolizumab
ItalyDrugs containing this active substance
-
It is used in adults and adolescents (from 12 years of age and older) for the treatment of moderate to severe atopic dermatitis. In adults, it is also indicated for the treatment of moderate to severe prurigo nodularis.
Form: solution for injection, powder and solvent for pre-filled pen
Active substance Dosage nemolizumab - ATC: D11AH12
Manufacturer: GALDERMA INTERNATIONAL